Literature DB >> 10213047

Jagged1 mutations in patients ascertained with isolated congenital heart defects.

I D Krantz1, R Smith, R P Colliton, H Tinkel, E H Zackai, D A Piccoli, E Goldmuntz, N B Spinner.   

Abstract

Mutations in Jagged1 cause Alagille syndrome (AGS), a pleiotropic disorder with involvement of the liver, heart, skeleton, eyes, and facial structures. Cardiac defects are seen in more than 95% of AGS patients. Most commonly these are right-sided defects ranging from mild peripheral pulmonic stenosis to severe forms of tetralogy of Fallot. AGS demonstrates highly variable expressivity with respect to all of the involved systems. This leads us to hypothesize that defects in Jagged1 can be found in patients with presumably isolated heart defects, such as tetralogy of Fallot or pulmonic stenosis. Two patients with heart defects of the type seen in AGS and their relatives were investigated for alterations in the Jagged1 gene. Jagged1 was screened by a combination of cytogenetic and molecular techniques. Patient 1 was studied because of a four-generation history of pulmonic stenosis. Molecular analysis showed a point mutation in Jagged1 in the patient and her mother. Patient 2 was investigated owing to the finding of tetralogy of Fallot and a "butterfly" vertebra on chest radiograph first noted at age 5 years. She was found to have a deletion of chromosome region 20p12 that encompassed the entire Jagged1 gene. The identification of these two patients suggests that other patients with right-sided heart defects may have subtle findings of AGS and Jagged1 mutations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10213047

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  23 in total

1.  Loss of Gata5 in mice leads to bicuspid aortic valve.

Authors:  Brigitte Laforest; Gregor Andelfinger; Mona Nemer
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

Review 2.  Alagille syndrome: pathogenesis, diagnosis and management.

Authors:  Peter D Turnpenny; Sian Ellard
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

Review 3.  Building a heart: implications for congenital heart disease.

Authors:  Deepak Srivastava
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

Review 4.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

5.  Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis.

Authors:  Robert C Bauer; Ayanna O Laney; Rosemarie Smith; Jennifer Gerfen; Jennifer J D Morrissette; Stacy Woyciechowski; Jennifer Garbarini; Kathleen M Loomes; Ian D Krantz; Zsolt Urban; Bruce D Gelb; Elizabeth Goldmuntz; Nancy B Spinner
Journal:  Hum Mutat       Date:  2010-05       Impact factor: 4.878

Review 6.  The neural crest in cardiac congenital anomalies.

Authors:  Anna Keyte; Mary Redmond Hutson
Journal:  Differentiation       Date:  2012-05-15       Impact factor: 3.880

7.  The keeshond defect in cardiac conotruncal development is oligogenic.

Authors:  Petra Werner; Michael G Raducha; Ulana Prociuk; Elaine A Ostrander; Richard S Spielman; Ewen F Kirkness; Donald F Patterson; Paula S Henthorn
Journal:  Hum Genet       Date:  2005-02-12       Impact factor: 4.132

Review 8.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

9.  Conditional JAG1 mutation shows the developing heart is more sensitive than developing liver to JAG1 dosage.

Authors:  Fengmin Lu; Jennifer J D Morrissette; Nancy B Spinner
Journal:  Am J Hum Genet       Date:  2003-03-14       Impact factor: 11.025

10.  Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome.

Authors:  Jennifer J Hofmann; Anais Briot; Josephine Enciso; Ann C Zovein; Shuxun Ren; Zhen W Zhang; Freddy Radtke; Michael Simons; Yibin Wang; M Luisa Iruela-Arispe
Journal:  Development       Date:  2012-10-24       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.